Sunday, February 11, 2024 7:23:27 PM
You may be interested in the upcoming instalment of the InnovateUK TMM CoP SME Showcase webinar series in which industry experts James Rutley (Autolomous) and Yatindra Tirunagari (Rentschler Biopharma SE) will delve into the many ways digital technologies are revolutionising the field of medicines manufacturing.
🗓️Date: Tuesday 13th of February
⏰Time: 10:00 AM - 11:00 AM GMT
🔗Register: https://rb.gy/vcybit
Expect deep dives into topics such as:
👉 The cutting-edge advancements in digital tools for advanced therapies
👉 How the successful implementation of such technologies can improve efficiency, scalability, and accessibility of these life-saving treatments
👉 Navigating the challenges and exciting opportunities associated with digital transformation.
Engage with the Innovate UK #TMMCoP and hear from funded SMEs on how digital technologies are shaping the future of medicines manufacturing.
— Innovate UK Business Connect (@IUK_Connect) February 2, 2024
Join us on 13 Feb at 10am
Register here> https://t.co/M4dzAuSWK9 #TransformingMedicinesManufacturing #DigitalTransformation pic.twitter.com/nuU7YgQmDq
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM